atrial fibrillation

PRADAXA 150 mg twice daily provided an additional 35% risk reduction of stroke/systemic embolism vs warfarin Superior reduction of ischemic and hemorrhagic stroke vs warfarin Similar rate of major bleeds‡ with PRADAXA vs warfarin PRADAXA is the ONLY anticoagulant to demonstrate superior reduction of ischemic stroke vs warfarin PRADAXA also demonstrated a lower rate of…